In this pilot study, the acute practice of the novel RVT improved the ISF glucose concentration, FGF21 and myostatin levels, and muscle stiffness and fatigue in middle-aged and older adults with obesity. The gene discussed is MSTN; the disease is obesity due to melanocortin 4 receptor deficiency.